National AIDS Treatment Advocacy Project (NATAP)

NATAP is a New York State non-profit corporation with 501(c)3 Federal tax-exempt status. NATAP mission is to educate individuals about HIV and Hepatitis treatments and to advocate on the behalf of all people living with HIV/AIDS and HCV. Their efforts in these areas are conducted on local, national, and international levels.

Locally, NATAP collaborates with other organizations as well as city and state agencies. Nationally, NATAP works with Federal agencies such as the Food and Drug Administration and the National Institute of Health and advocates on policy and treatment issues. Jules Levin, Their Executive Director, is a community representative to the AIDS Clinical Trials Group (ACTG) and the HIV Disease Research Agenda Committee (RAC) of the ACTG, where the Federal government conducts its HIV research.

The treatment information that NATAP provides reaches medical professionals, allied professionals, patients, caregivers, underserved communities, and other interested parties in over 40 countries.